Page last updated: 2024-09-05

darunavir and cardiovascular agents

darunavir has been researched along with cardiovascular agents in 3 studies

Compound Research Comparison

Studies
(darunavir)
Trials
(darunavir)
Recent Studies (post-2010)
(darunavir)
Studies
(cardiovascular agents)
Trials
(cardiovascular agents)
Recent Studies (post-2010) (cardiovascular agents)
1,14822478017,6451,4806,891

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Clotet, B; Moltó, J; Valle, M1
Berginc, K; Kristl, A1
Battegay, M; Cavassini, M; Courlet, P; Decosterd, L; Marzolini, C; Saldanha, SA; Stader, F; Stoeckle, M1

Reviews

1 review(s) available for darunavir and cardiovascular agents

ArticleYear
[Pharmacological interactions with darunavir].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 10

    Topics: Anti-HIV Agents; Anti-Infective Agents; Anti-Ulcer Agents; Cardiovascular Agents; Contraceptives, Oral, Hormonal; Cytochrome P-450 CYP3A; Darunavir; Drug Interactions; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Microsomes, Liver; Phosphodiesterase Inhibitors; Ritonavir; Selective Serotonin Reuptake Inhibitors; Sulfonamides

2008

Other Studies

2 other study(ies) available for darunavir and cardiovascular agents

ArticleYear
The mechanisms responsible for garlic - drug interactions and their in vivo relevance.
    Current drug metabolism, 2013, Volume: 14, Issue:1

    Topics: Animals; Antiviral Agents; Biological Transport; Caco-2 Cells; Cardiovascular Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Darunavir; Garlic; Hep G2 Cells; Hepatocytes; Herb-Drug Interactions; Humans; Intestine, Small; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Plant Extracts; Rats; Rats, Wistar; Reproducibility of Results; Sulfonamides

2013
Aging does not impact drug--drug interaction magnitudes with antiretrovirals.
    AIDS (London, England), 2020, 05-01, Volume: 34, Issue:6

    Topics: Aged; Aged, 80 and over; Aging; Amlodipine; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Atorvastatin; Cardiovascular Agents; Cardiovascular Diseases; Darunavir; Drug Interactions; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Rosuvastatin Calcium; Treatment Outcome

2020